Caseware UK (AP4) 2024.0.164 2024.0.164 2025-07-312025-07-312024-08-01falseNo description of principal activity44truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 08162405 2024-08-01 2025-07-31 08162405 2023-08-01 2024-07-31 08162405 2025-07-31 08162405 2024-07-31 08162405 c:Director1 2024-08-01 2025-07-31 08162405 d:ComputerEquipment 2024-08-01 2025-07-31 08162405 d:ComputerEquipment 2025-07-31 08162405 d:ComputerEquipment 2024-07-31 08162405 d:CurrentFinancialInstruments 2025-07-31 08162405 d:CurrentFinancialInstruments 2024-07-31 08162405 d:CurrentFinancialInstruments d:WithinOneYear 2025-07-31 08162405 d:CurrentFinancialInstruments d:WithinOneYear 2024-07-31 08162405 d:ShareCapital 2025-07-31 08162405 d:ShareCapital 2024-07-31 08162405 d:RetainedEarningsAccumulatedLosses 2025-07-31 08162405 d:RetainedEarningsAccumulatedLosses 2024-07-31 08162405 c:FRS102 2024-08-01 2025-07-31 08162405 c:AuditExempt-NoAccountantsReport 2024-08-01 2025-07-31 08162405 c:FullAccounts 2024-08-01 2025-07-31 08162405 c:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 08162405 2 2024-08-01 2025-07-31 08162405 6 2024-08-01 2025-07-31 08162405 e:PoundSterling 2024-08-01 2025-07-31 iso4217:GBP xbrli:pure

Registered number: 08162405










PT ENTERPRISES EUROPE LIMITED








UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JULY 2025

 
PT ENTERPRISES EUROPE LIMITED
REGISTERED NUMBER: 08162405

STATEMENT OF FINANCIAL POSITION
AS AT 31 JULY 2025

2025
2024
Note
£
£

Fixed assets
  

Investments
 5 
100
100

Current assets
  

Debtors: amounts falling due within one year
 6 
65,487
20,173

Cash at bank and in hand
 7 
2,506
21,736

  
67,993
41,909

Creditors: amounts falling due within one year
 8 
(61,333)
(110,302)

Net current assets/(liabilities)
  
 
 
6,660
 
 
(68,393)

  

Net assets/(liabilities)
  
6,760
(68,293)


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
6,660
(68,393)

  
6,760
(68,293)


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 

J D Melton
Director

Date: 4 December 2025

The notes on pages 2 to 8 form part of these financial statements.
Page 1

 
PT ENTERPRISES EUROPE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025

1.


General information

PT Enterprises Europe Limited is a private company, limited by shares, registered in England and Wales. The Company's registration number is 08162405. The registered office and principal place of business is 10 Queen Street Place, London EC4R 1AG. 
The principal activity is providing drug development services to contract research organizations, pharmaceutical and biotechnology industries via a global consultancy. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Page 2

 
PT ENTERPRISES EUROPE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025

2.Accounting policies (continued)

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.5

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of Financial Position. The assets of the plan are held separately from the Company in independently administered funds.

 
2.6

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 3

 
PT ENTERPRISES EUROPE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025

2.Accounting policies (continued)


2.6
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Computer equipment
-
25%
straight-line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.7

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

 
2.8

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.9

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.10

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.11

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Page 4

 
PT ENTERPRISES EUROPE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025

2.Accounting policies (continued)


2.11
Financial instruments (continued)

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

Other financial assets

Other financial assets, which includes investments in equity instruments which are not classified as subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the recognised transaction price. Such assets are subsequently measured at fair value with the changes in fair value being recognised in the profit or loss. Where other financial assets are not publicly traded, hence their fair value cannot be measured reliably, they are measured at cost less impairment.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.


3.


Employees

The average monthly number of employees, including directors, during the year was 4 (2024 - 4).




Page 5

 
PT ENTERPRISES EUROPE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025

4.


Tangible fixed assets





Computer equipment

£



Cost or valuation


At 1 August 2024
2,915



At 31 July 2025

2,915



Depreciation


At 1 August 2024
2,915



At 31 July 2025

2,915



Net book value



At 31 July 2025
-



At 31 July 2024
-


5.


Fixed asset investments





Investments in subsidiary companies

£



Cost or valuation


At 1 August 2024
100



At 31 July 2025
100




Page 6

 
PT ENTERPRISES EUROPE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025

6.


Debtors

2025
2024
£
£


Amounts owed by group undertakings
60,251
-

Amounts owed by related parties
2,080
2,080

Other debtors
1,029
6,882

Prepayments and accrued income
2,127
11,211

65,487
20,173



7.


Cash and cash equivalents

2025
2024
£
£

Cash at bank and in hand
2,506
21,736



8.


Creditors: Amounts falling due within one year

2025
2024
£
£

Trade creditors
549
-

Amounts owed to group undertakings
-
101,388

Other creditors
53,983
2,738

Accruals
6,801
6,176

61,333
110,302



9.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The pension cost represents contributions payable by the Company to the fund and amount to £3,454 (2024 - £2,165).

Page 7

 
PT ENTERPRISES EUROPE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025

10.


Related party transactions

Included within amounts owed by group undertakings is an amount of £60,251 due from Momentum Pharma Limited (2024: £101,388 due to Momentum Pharma Limited). The balance is unsecured, interest free and repayable on demand. This entity is considered a related party due to common ownership and control.
Included within amounts owed by related parties is an amount of £2,080 (2024: £2,080) due from Momentum Pharma Inc. The balance is unsecured, interest free and repayable on demand. This entity is considered a related party due to common ownership and control.
Included within other creditors is an amount of £48,495 due to the directors (2024: £5,166 due from the directors). These balances are unsecured, interest-free and repayable on demand.


11.


Controlling party

The Company is jointly controlled by Mr J D Melton and Mrs M G Melton.

 
Page 8